Horizon Health expanding to Tilton
TILTON, Ill. (WCIA) — One Vermillion County Village is getting a new Horizon Health clinic to help meet people's needs in town.
It will be a family medicine clinic in Tilton — which means it can handle common medical issue like strep throat and the flu. It will be available for both appointments and walk-ins, and it will initially be staffed by three employees: one advanced practice doctor and two clinical support staff.
Health Alliance discontinuing plans at year's end; Medicare Advantage to continue
'According to the builder, when we came in here and looked this over, he was explaining to me, this is going to be like a small lab area where they help diagnose problems people are having,' Tilton Mayor William Wear said. 'Over here is going to be the nurses station. And if my understanding is right, back in here somewhere is where the refrigeration units are going to go in, where they're going to keep the medication and all that.'
Horizon said they're looking to hire a nurse practitioner or physician's assistant for the facility's main position.
The plan is for the clinic to open by June of this year. Mayor Wear said it may expand to a five-acre lot in the future based on the needs of people in and around Tilton.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge
Most of UnitedHealth Group's issues should be temporary. The two biggest threats to the healthcare giant are iffy. The price is right to buy UnitedHealth Group stock after its steep decline. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." The latter better captures the feelings of the healthcare giant's shareholders in recent months. A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set in the fourth quarter of 2024. Some analysts have downgraded the stock, with HSBC recommending that investors reduce their holdings and slashing its price target. I have a different opinion, though. I think it's time to buy UnitedHealth Group stock. Here are three reasons why. I don't think investors should ignore UnitedHealth Group's issues. However, the challenges should be viewed with a long-term perspective. I suspect most of the problems the company faces should be temporary. UnitedHealth Group has already largely moved past the cyberattack that occurred in February 2024. Although it cost the healthcare company over $2 billion, that issue has already proven to be a short-lived one. Higher Medicare Advantage costs are the main culprit behind UnitedHealth Group's suspension of its 2025 full-year guidance. But the company says that it expects to return to growth in 2026. I believe this prediction because it makes sense. Insurers sometimes incur higher-than-anticipated costs and feel the pain for a while. However, once they adjust premiums, the problem goes away. UnitedHealth Group announced the sudden departure of former CEO Andrew Witty at the same time it withdrew its 2025 outlook. Any worries investors might have had surrounding this move probably dissipated quickly after they learned Stephen Hemsley was returning to run the company. Hemsley served as CEO from 2006 through 2017, a period when UnitedHealth Group stock more than tripled. I also view the two biggest threats to UnitedHealth Group as iffy. What are those threats? An alleged U.S. Department of Justice criminal investigation of the company and President Trump's stated goal to eliminate pharmacy benefits managers (PBMs). Noted that I used the word "alleged" to describe the U.S. Department of Justice probe. The Wall Street Journal reported on May 14, 2025, that "people familiar with the matter" revealed that the DOJ had launched a criminal investigation of UnitedHealth Group for possible Medicare fraud. However, the company quickly responded that it hadn't been notified of any DOJ investigation. That status hasn't changed. President Trump did announce that he wants to "cut out the middleman," a clear reference to PBMs. That's easier said than done, though, to put it mildly. Removing PBMs from the U.S. healthcare system would require a detailed, comprehensive plan that so far has not been provided. That plan would also have to pass in both the Senate and the House of Representatives. You can bet that the PBM industry, including UnitedHealth Group, would lobby fiercely against any such legislation. I think this threat, while serious, has a relatively low probability of actually materializing. Finally, I think all these issues are fully baked into UnitedHealth Group's share price. The stock currently trades at a forward price-to-earnings ratio of around 13.3. That's well below the S&P 500 healthcare sector forward earnings multiple of 16.6. It's also the lowest valuation for UnitedHealth Group in more than a decade. Could the stock fall further? Maybe, but I believe that UnitedHealth Group's share price has bottomed out. You might have noticed that UnitedHealth Group's share price has traded in a relatively narrow range since the steep decline in April and May. This trading pattern seems to confirm my view. Any good news for UnitedHealth Group could provide a nice catalyst. I predict that the company will have some positive developments in the not-too-distant future, potentially including new full-year guidance that calms investors. If I'm right, buying UnitedHealth Group stock now could pay off handsomely. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 HSBC Holdings is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings and UnitedHealth Group. The Motley Fool has a disclosure policy. Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
BDC Advisors Appoints Carrie Knowles-Atkinson as Principal, Supporting Continued Growth of the Payer-Provider Strategy Practice
MIAMI, June 12, 2025 /PRNewswire/ -- BDC Advisors, a leading healthcare strategy consulting firm, is pleased to announce the appointment of Carrie Knowles-Atkinson as a Principal. Carrie brings over 25 years of leadership in provider network strategy, contract negotiation, and payer-provider collaboration to support BDC's growing practice focused on payer-provider strategy, innovation and value-based contracting. Carrie has held senior leadership roles across the healthcare industry, including nearly two decades at UnitedHealth Group (UnitedHealthcare and Optum), where she served as National Vice President of Provider Networks and Regional Vice President of Government Network Programs. Most recently, she served as a Senior Healthcare Advisor at Oliver Wyman, where she worked with leading payers to optimize provider networks and contracting strategies. Her experience spans all major lines of business including Commercial, Medicare Advantage, Medicaid, Exchange, and Federal programs. "By bringing deep payer expertise to payer-provider strategy, we've consistently delivered client value through significant improvement in financial performance," said Shawn Fitzgibbon, Managing Director at BDC Advisors. "Carrie's operational excellence, strategic insight, and breadth of experience will help our clients address complex market dynamics and achieve sustainable growth." At BDC, Carrie will work with health systems, provider organizations, and health plans to align contracting strategies with service line transformation efforts and enterprise growth. Her appointment comes as BDC Advisors continues to expand its payer-provider innovation services, including product development, go-to-market strategies, revenue enhancement, market competitive repositioning, development of value-based payment models, and implementation of sustainable contracting cycles. Carrie holds an MBA from the University of Florida and completed UnitedHealth Group's Executive Development Program through Stanford University. ABOUT BDC ADVISORS BDC Advisors is a national healthcare strategy consulting firm that supports the transformation and growth of healthcare organizations. The firm's practice focuses on advising and providing service to academic health systems, as well as community, regional, and multi-state providers on issues surrounding enterprise strategy, organizational development and design, payer-provider innovation, population health strategy, and physician alignment. BDC Advisors has a culture of inclusion and is a founding supporter of the Carol Emmott Foundation, which supports a national fellowship program for women leaders in healthcare, designed to accelerate their executive careers. For further information, contact:Christina TellecheaProject Management Associate396454@ View original content to download multimedia: SOURCE BDC Advisors 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
10 hours ago
- Yahoo
Bill banning AI therapy bots in Illinois awaits signature
SPRINGFIELD, Ill. (WCIA) — Illinois could soon require humans to be in charge of all therapy sessions. The Illinois Legislature passed a bill to the governor's desk that would ban the use of therapy offered by Artificial Intelligence. Mental health professionals would also only be able to use AI transcriptions of sessions if the patient consents to it. Illinois bill ending scam gym membership tactic heads to governor's desk The National Association for Social Workers said while artificial intelligence could be a promising tool in the future, right now it is not bound by ethics. 'These AI chat bots, even though you can try to program as best as you can, they're not human,' said Kyle Hillman, the legislative director for NASW-IL. 'They don't have that interaction they don't have that kind of response. And so, they're influenced by what kind of data comes into those products and that influence is changing the biases towards, I think, dangerous conservations.' Durbin pushes to pass DACA bill ahead of 13th anniversary The bill's House sponsor said guardrails need to be set in stone before technology advances too far. 'Our behavioral healthcare system cannot afford to be replaced by unqualified chatbots with no malpractice liability,' Rep. Bob Morgan (D-Deerfield) said in a news release. 'By explicitly laying out what AI technology can and cannot be used for, patients are better protected, providers can continue delivering critical access to care, and treatment plans remain transparent between the client and professional.' If signed into law, Illinois would be the first state to ban these chatbots. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
